CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 22,640 | ||
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −842 | $610.29 | $514K | 325,324 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −403 | $611.26 | $246K | 324,921 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −398 | $612.06 | $244K | 324,523 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $613.14 | $49K | 324,443 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −39 | $580.70 | $23K | 333,904 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −133 | $582.18 | $77K | 333,771 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −188 | $583.18 | $110K | 333,583 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $584.14 | $47K | 333,503 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $585.60 | $164K | 333,223 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $586.92 | $164K | 332,943 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $588.21 | $235K | 332,543 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −50 | $590.05 | $30K | 332,493 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $591.07 | $71K | 332,373 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −214 | $592.27 | $127K | 332,159 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −216 | $593.37 | $128K | 331,943 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $594.60 | $95K | 331,783 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $596.22 | $191K | 331,463 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −477 | $597.56 | $285K | 330,986 |
Page 7 of 64 · 1,267 trades